ENTERAL ACCESS TECHNOLOGIES LTD

ENTERAL ACCESS TECHNOLOGIES LTD

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Persons with signficant control statements
  • Data Source
  • Overview

    Company NameENTERAL ACCESS TECHNOLOGIES LTD
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 11367892
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of ENTERAL ACCESS TECHNOLOGIES LTD?

    • Manufacture of medical and dental instruments and supplies (32500) / Manufacturing

    Where is ENTERAL ACCESS TECHNOLOGIES LTD located?

    Registered Office Address
    131 Mount Pleasant
    L3 5TF Liverpool
    England
    Undeliverable Registered Office AddressNo

    What were the previous names of ENTERAL ACCESS TECHNOLOGIES LTD?

    Previous Company Names
    Company NameFromUntil
    NASOGASTRIC FEEDING SOLUTIONS LTDMay 17, 2018May 17, 2018

    What are the latest accounts for ENTERAL ACCESS TECHNOLOGIES LTD?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnMay 31, 2026
    Next Accounts Due OnFeb 28, 2027
    Last Accounts
    Last Accounts Made Up ToMay 31, 2025

    What is the status of the latest confirmation statement for ENTERAL ACCESS TECHNOLOGIES LTD?

    Last Confirmation Statement Made Up ToMay 16, 2026
    Next Confirmation Statement DueMay 30, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMay 16, 2025
    OverdueNo

    What are the latest filings for ENTERAL ACCESS TECHNOLOGIES LTD?

    Filings
    DateDescriptionDocumentType

    Micro company accounts made up to May 31, 2025

    4 pagesAA

    Statement of capital following an allotment of shares on Jan 28, 2026

    • Capital: GBP 4,348,228.772
    3 pagesSH01

    Statement of capital following an allotment of shares on Nov 27, 2025

    • Capital: GBP 4,294,690.322
    3 pagesSH01

    Statement of capital following an allotment of shares on Apr 30, 2020

    • Capital: GBP 4,232,190.322
    3 pagesSH01

    Statement of capital following an allotment of shares on Nov 19, 2025

    • Capital: GBP 4,223,985.492
    3 pagesSH01

    Statement of capital following an allotment of shares on Nov 03, 2025

    • Capital: GBP 4,075,908.582
    3 pagesSH01

    Statement of capital following an allotment of shares on Oct 06, 2025

    • Capital: GBP 3,968,190.322
    3 pagesSH01

    Statement of capital following an allotment of shares on Aug 28, 2025

    • Capital: GBP 3,869,151.892
    3 pagesSH01

    Confirmation statement made on May 16, 2025 with updates

    16 pagesCS01

    Statement of capital following an allotment of shares on May 12, 2025

    • Capital: GBP 3,667,228.902
    3 pagesSH01

    Micro company accounts made up to May 31, 2024

    4 pagesAA

    Statement of capital following an allotment of shares on Jan 24, 2025

    • Capital: GBP 3,532,613.5420
    4 pagesSH01

    Statement of capital following an allotment of shares on Dec 18, 2024

    • Capital: GBP 3,487,421.252
    4 pagesSH01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Memorandum and Articles of Association

    28 pagesMA

    Termination of appointment of David Coulson Stonehouse as a director on Jul 31, 2024

    1 pagesTM01

    Statement of capital following an allotment of shares on May 20, 2024

    • Capital: GBP 3,274,299.112
    4 pagesSH01

    Confirmation statement made on May 16, 2024 with updates

    14 pagesCS01

    Statement of capital following an allotment of shares on Apr 29, 2024

    • Capital: GBP 3,178,145.2720
    4 pagesSH01

    Statement of capital following an allotment of shares on Mar 22, 2024

    • Capital: GBP 3,168,529.892
    4 pagesSH01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Memorandum and Articles of Association

    26 pagesMA

    Statement of capital following an allotment of shares on Feb 29, 2024

    • Capital: GBP 3,168,433.7420
    8 pagesSH01

    Statement of capital following an allotment of shares on Dec 22, 2023

    • Capital: GBP 2,878,752.1220
    4 pagesSH01

    Statement of capital following an allotment of shares on Apr 03, 2023

    • Capital: GBP 1,636,532.4920
    4 pagesSH01

    Who are the officers of ENTERAL ACCESS TECHNOLOGIES LTD?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    ERWIN, Austin Andrew Sindelka
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    Director
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    United KingdomBritish29009170002
    GALLAGHER, George
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    Director
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    United KingdomBritish86148880003
    SHAUGHNESSY, Michael
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    Director
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    United StatesAmerican272746500001
    STONEHOUSE, David Coulson
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    Director
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    United KingdomBritish44113920002

    Who are the persons with significant control of ENTERAL ACCESS TECHNOLOGIES LTD?

    Persons with significant controls
    NameNotified OnAddressCeased
    Mr George Gallagher
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    May 17, 2018
    Mount Pleasant
    L3 5TF Liverpool
    131
    England
    Yes
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    What are the latest statements on persons with significant control for ENTERAL ACCESS TECHNOLOGIES LTD?

    Persons with signficant control statements
    Notified OnCeased OnStatement
    Feb 01, 2023The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0